Tag Archives: Advertising
Feds Chase Down Faulty Skincare Promos
FDA’s Division of Drug Marketing Communications, this week, posted a slew of warning and untitled letters to pharma firms for misleading skincare advertisements. Johnson & Johnson, Galderma, and Allergan each received a letter documenting complaints ranging from false advertising to unsubstantial efficacy claims.
J&J received a violation letter in response to a journal ad for its [...]
Posted in FDA, Marketing Also tagged Allergan, Clinical trial, Johnson & Johnson, U.S. Food and Drug Administration 2 Comments
Building a Better Brief Summary
Image via Wikipedia
FDA wanted to find out what people really think of the risk information printed on the back of pharmaceutical advertising. Surprise, people tend to absorb far less information from the giant blocks of text printed in drab language.
DDMAC social science analyst Amy O’Donoghue explained FDA’s recent study results to an audience of marketers [...]
Is FDA Watching YouTube?
Two weeks ago, Shire received a warning letter for posting a sponsored testimonial on YouTube without including risk information. Shire was very open when I called them up and admitted that the video was posted by accident and immediately removed when it was brought to the company’s attention.
While I’m not 100 percent positive, it [...]
Posted in E-Media, Marketing, Regulatory Also tagged DDMAC, DTC, emedia, FDA, Shire, Viagra, Warning Letter, YouTube 6 Comments

Pfizer Quietly Updates Company Logo